Good morning :)
Aarey Drugs and Pharmaceuticals Ltd

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS Share Price

NSE
₹106.264.13% (-4.58)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹338 cr, stock is ranked 2,278

High Risk

Stock is 3.71x as volatile as Nifty

AAREYDRUGS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹338 cr, stock is ranked 2,278

High Risk

Stock is 3.71x as volatile as Nifty

AAREYDRUGS Performance & Key Metrics

AAREYDRUGS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
81.032.25—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
45.815.760.50%

AAREYDRUGS Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AAREYDRUGS Company Profile

Aarey Drugs & Pharmaceuticals is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing.

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Limited
SUNPHARMA
PE Ratio
37.16
37.16
1Y Return
4.36%
4.36%
Buy Reco %
93.33
93.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
81.11
81.11
1Y Return
28.06%
28.06%
Buy Reco %
85.19
85.19
Laurus Labs Ltd
LAURUSLABS
PE Ratio
146.23
146.23
1Y Return
147.90%
147.90%
Buy Reco %
61.54
61.54
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
24.65
24.65
1Y Return
26.30%
26.30%
Buy Reco %
57.69
57.69
Dr. Reddy's Laboratories Limited
DRREDDY
PE Ratio
26.84
26.84
1Y Return
12.46%
12.46%
Buy Reco %
67.74
67.74
Compare with Peers

AAREYDRUGS Forecast

AAREYDRUGS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

AAREYDRUGS

AAREYDRUGS

Income

Balance Sheet

Cash Flow

AAREYDRUGS Income Statement

AAREYDRUGS Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue215.49128.49105.16134.47115.64103.7684.95100.61189.0446.34
Operating & Other expensessubtract211.79125.73101.42131.59112.30100.5181.5297.94185.1343.30
Depreciation/Amortizationsubtract1.150.471.510.900.410.490.690.830.850.85
Interest & Other Itemssubtract0.400.960.490.581.301.041.260.921.781.67
Taxes & Other Itemssubtract-0.010.090.150.681.160.360.460.35-0.28-0.51
EPS0.770.440.570.260.170.480.360.200.550.36
See Costs

EPS in ₹. Other numbers in ₹ cr

AAREYDRUGS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual report

PDF
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
 

AAREYDRUGS Stock Peers

AAREYDRUGS Past Performance & Peer Comparison

AAREYDRUGS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Aarey Drugs and Pharmaceuticals Ltd84.892.25—
Sun Pharmaceutical Industries Limited37.165.090.90%
Torrent Pharmaceuticals Ltd81.119.980.73%
Laurus Labs Ltd146.2323.930.08%
ScreenerCompare valuation on Screener

AAREYDRUGS Stock Price Comparison

Compare AAREYDRUGS with any stock or ETF
Compare AAREYDRUGS with any stock or ETF
AAREYDRUGS
Loading...

AAREYDRUGS Holdings

AAREYDRUGS Shareholdings

AAREYDRUGS Promoter Holdings Trend

AAREYDRUGS Promoter Holdings Trend

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 3.74%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AAREYDRUGS Institutional Holdings Trend

AAREYDRUGS Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.72%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AAREYDRUGS Shareholding Pattern

AAREYDRUGS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding41.45%0.00%1.44%4.27%52.83%

Mar 2026

Jun 2026

Aug 2026

Sep 2026

AAREYDRUGS Shareholding History

AAREYDRUGS Shareholding History

SepDec '25MarJunAugSep1.13%3.86%4.18%4.80%4.41%4.27%

AAREYDRUGS Insider Trades & Bulk Stock Deals

AAREYDRUGS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing AAREYDRUGS stock

smallcases containing AAREYDRUGS stock

Looks like this stock is not in any smallcase yet.

AAREYDRUGS Events

AAREYDRUGS Events

AAREYDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AAREYDRUGS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

AAREYDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AAREYDRUGS has not given any dividends in last 5 years

AAREYDRUGS Upcoming Dividends

AAREYDRUGS Upcoming Dividends

No upcoming dividends are available

AAREYDRUGS Past Dividends

AAREYDRUGS Past Dividends

Cash Dividend

Ex DateEx DateDec 13, 2018

Interim
Interim | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Dec 13, 2018

AAREYDRUGS Stock News & Opinions

AAREYDRUGS Stock News & Opinions

Corporate
Corporate
Aarey Drugs receives certificate from MUFG Intime for period ending September 30, 2026

Aarey Drugs & Pharmaceuticals Limited informed the BSE Limited and National Stock Exchange of India Limited that it has received a certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026.

3 weeks agoCapital Market - Live
Corporate
Corporate
Aarey Drugs restricts insider trading ahead of September 2026 financial results release

Aarey Drugs and Pharmaceuticals Limited will close its trading window for insiders, designated persons, and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations and circulars issued by the BSE and NSE.

1 month agoCapital Market - Live
Corporate
Corporate
AAREY DRUGS to convene board meeting for quarterly results announcement on August 14

AAREY DRUGS & PHARMACEUTICALS LIMITED will hold a board meeting on Friday, August 14, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026, and other matters, according to a filing with the BSE Limited and National Stock Exchange of India Limited. Trading window for the company will be closed from July 1, 2026, and will remain closed until 48 hours after the announcement of the financial results.

2 months agoCapital Market - Live
Earnings
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit rises 231.91% in the March 2026 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 231.91% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.47 crore during the previous quarter ended March 2025. Sales rose 75.27% to Rs 189.47 crore in the quarter ended March 2026 as against Rs 108.10 crore during the previous quarter ended March 2025. For the full year,net profit declined 1.24% to Rs 3.97 crore in the year ended March 2026 as against Rs 4.02 crore during the previous year ended March 2025. Sales declined 0.35% to Rs 472.27 crore in the year ended March 2026 as against Rs 473.94 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales189.47108.10 75 472.27473.94 0 OPM %2.29-3.89 -1.520.61 - PBDT2.132.04 4 8.268.04 3 PBT1.281.63 -21 5.416.10 -11 NP1.560.47 232 3.974.02 -1 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Corporate
Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

5 months agoCapital Market - Live
Earnings
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 20.83% in the December 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 20.83% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.72 crore during the previous quarter ended December 2024. Sales declined 27.92% to Rs 96.43 crore in the quarter ended December 2025 as against Rs 133.79 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales96.43133.79 -28 OPM %-1.571.64 - PBDT1.752.30 -24 PBT0.921.40 -34 NP0.570.72 -21 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Corporate
Aarey Drugs & Pharmaceuticals to discuss results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 36.25% in the September 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 36.25% to Rs 1.02 crore in the quarter ended September 2025 as against Rs 1.60 crore during the previous quarter ended September 2024. Sales declined 19.95% to Rs 84.16 crore in the quarter ended September 2025 as against Rs 105.14 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales84.16105.14 -20 OPM %3.143.55 - PBDT2.173.26 -33 PBT1.481.75 -15 NP1.021.60 -36 Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Corporate
Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Corporate
Aarey Drugs & Pharmaceuticals to hold AGM

Aarey Drugs & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

  1. The share price of AAREYDRUGS as on 30th October 2026 is ₹106.26. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share are
    • Past 1 week: -2.43%
    • Past 1 month: 6.14%
    • Past 3 months: 37.79%
    • Past 6 months: 16.67%
    • Past 1 year: 14.12%
    • Past 3 years: 158.23%
    • Past 5 years: 216.72%

  3. The peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) include:

  4. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹338.70 Cr as of 30th October 2026.

  5. The 52-week high of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹114.80 and the 52-week low is ₹50.31.

  6. The P/E (price-to-earnings) ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is 84.89. The P/B (price-to-book) ratio is 2.25.

  7. Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. You can directly buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares on Tickertape. Simply sign up, connect your demat account and place your order.